Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Young-Min

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|September 28, 2004
Copying clinic letters to patients will place additional demands on both secondary and primary care: a hospital outpatient questionnaireS A Young-Min, J Hamilton, C Heycock, et al.
Annals of the Rheumatic Diseases|June 2, 2001
Markers of joint destruction: principles, problems, and potentialS A Young-Min, T E Cawston, I D Griffiths
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 30, 2009
Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?M H Edwards, F C McCrae, S A Young-Min
Rheumatology (Oxford, England)|December 22, 2004
Weekly alendronate-induced acute pseudogoutS A Young-Min, L Herbert, M Dick, et al.
Rheumatology (Oxford, England)|December 26, 2008
Possible miliary tuberculosis during adalimumab therapy with negative gamma-IFN release assaysA L Endean, S M Barry, S A Young-Min
The British Journal of Dermatology|May 15, 2009
Successful treatment of multicentric reticulohistiocytosis with leflunomideA A Lonsdale-Eccles, A E Haworth, F C McCrae, et al.
Journal of Clinical Pathology|January 30, 2007
Gross synovial fluid analysis in the differential diagnosis of joint effusionS Abdullah, S A Young-Min, S J Hudson, et al.
Annals of the Rheumatic Diseases|August 15, 2001
Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controlsS A Young-Min, C Beeton, R Laughton, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|September 28, 2004
Copying clinic letters to patients will place additional demands on both secondary and primary care: a hospital outpatient questionnaireS A Young-Min, J Hamilton, C Heycock, et al.
Annals of the Rheumatic Diseases|June 2, 2001
Markers of joint destruction: principles, problems, and potentialS A Young-Min, T E Cawston, I D Griffiths
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 30, 2009
Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?M H Edwards, F C McCrae, S A Young-Min
Rheumatology (Oxford, England)|December 22, 2004
Weekly alendronate-induced acute pseudogoutS A Young-Min, L Herbert, M Dick, et al.
Rheumatology (Oxford, England)|December 26, 2008
Possible miliary tuberculosis during adalimumab therapy with negative gamma-IFN release assaysA L Endean, S M Barry, S A Young-Min
The British Journal of Dermatology|May 15, 2009
Successful treatment of multicentric reticulohistiocytosis with leflunomideA A Lonsdale-Eccles, A E Haworth, F C McCrae, et al.
Journal of Clinical Pathology|January 30, 2007
Gross synovial fluid analysis in the differential diagnosis of joint effusionS Abdullah, S A Young-Min, S J Hudson, et al.
Annals of the Rheumatic Diseases|August 15, 2001
Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controlsS A Young-Min, C Beeton, R Laughton, et al.
Pageof 1